331 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
or desired, (c) no Placement Agent will have any responsibility with respect to (i) any representations, warranties or agreements made by any person or entity
8-K
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
of substantial responsibility and to motivate participants to optimize the profitability and growth of the combined company through incentives … and accounting functions. Prior to joining Protagonist, Mr. Agarwal served in various roles of increasing responsibility at McKesson Corporation (NYSE: MCK
8-K
EX-99.2
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
The financial statement is the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial
8-K
EX-10.10
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
of substantial responsibility and to motivate Participants to optimize the profitability and growth of the Company through incentives that are consistent
8-K
EX-10.25
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
this Agreement will be the sole responsibility of Consultant.
Invoicing. Consultant shall invoice Oruka in accordance with the invoice schedule … employees. All payroll and employment taxes, insurance and benefits shall be the sole responsibility of Consultant.
Page 2 of 10
4. Confidential
8-K
EX-14.1
06qemkvd2al6j qst
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
424B3
sll6ajqmvafsyfd 6gp0
1 Aug 24
Prospectus supplement
4:10pm
425
qq5q xpiws
3 Apr 24
Business combination disclosure
7:33am
8-K
EX-2.1
m6psllul
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am